609 related articles for article (PubMed ID: 28445298)
41. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
[TBL] [Abstract][Full Text] [Related]
42. Prognostic scores for sorafenib-treated hepatocellular carcinoma patients: A new application for the hepatoma arterial embolisation prognostic score.
Edeline J; Blanc JF; Campillo-Gimenez B; Ma YT; King J; Faluyi O; Mathurin J; Ghazi S; Palmer DH; Meyer T
Eur J Cancer; 2017 Nov; 86():135-142. PubMed ID: 28987770
[TBL] [Abstract][Full Text] [Related]
43. Analysis of survival factors in patients with intermediate-advanced hepatocellular carcinoma treated with transcatheter arterial chemoembolization combined with sorafenib.
Zheng J; Shao G; Luo J
Clin Transl Oncol; 2014 Nov; 16(11):1012-7. PubMed ID: 24894839
[TBL] [Abstract][Full Text] [Related]
44. Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma.
Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Park MS; Kim EH; Seong J; Lee DY; Han KH
Liver Int; 2012 Aug; 32(7):1120-7. PubMed ID: 22524688
[TBL] [Abstract][Full Text] [Related]
45. Survival analysis of proposed BCLC-B subgroups in hepatocellular carcinoma patients.
Weinmann A; Koch S; Sprinzl M; Kloeckner R; Schulze-Bergkamen H; Düber C; Lang H; Otto G; Wörns MA; Galle PR
Liver Int; 2015 Feb; 35(2):591-600. PubMed ID: 25290314
[TBL] [Abstract][Full Text] [Related]
46. The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma.
Wu FX; Chen J; Bai T; Zhu SL; Yang TB; Qi LN; Zou L; Li ZH; Ye JZ; Li LQ
BMC Cancer; 2017 Sep; 17(1):645. PubMed ID: 28899349
[TBL] [Abstract][Full Text] [Related]
47. Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA era.
Waziry R; Gomaa A; Waked I; Dore GJ
Arab J Gastroenterol; 2018 Mar; 19(1):26-32. PubMed ID: 29506913
[TBL] [Abstract][Full Text] [Related]
48. BCLC-B Subclassification and the Hong Kong Liver Cancer System in Intermediate Hepatocellular Carcinoma: Identifying Candidates for Curative Therapy.
Longo L; Rodrigues de Freitas LB; Santos D; Grivicich I; Álvares-da-Silva MR
Am J Clin Oncol; 2019 May; 42(5):466-471. PubMed ID: 30913090
[TBL] [Abstract][Full Text] [Related]
49. Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions.
Bolondi L; Burroughs A; Dufour JF; Galle PR; Mazzaferro V; Piscaglia F; Raoul JL; Sangro B
Semin Liver Dis; 2012 Nov; 32(4):348-59. PubMed ID: 23397536
[TBL] [Abstract][Full Text] [Related]
50. The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trial.
Chao Y; Chung YH; Han G; Yoon JH; Yang J; Wang J; Shao GL; Kim BI; Lee TY
Int J Cancer; 2015 Mar; 136(6):1458-67. PubMed ID: 25099027
[TBL] [Abstract][Full Text] [Related]
51. Addition of local hepatic therapy to sorafenib in patients with advanced hepatocellular carcinoma (stage BCLC C).
Schmidt L; op den Winkel M; Fischer K; Straub G; Rauch B; Paprottka PM; Göke B; Kolligs FT
Digestion; 2014; 90(4):219-28. PubMed ID: 25502689
[TBL] [Abstract][Full Text] [Related]
52. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
Han K; Kim JH
World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
[TBL] [Abstract][Full Text] [Related]
53. Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib.
Meng XC; Chen BH; Huang JJ; Huang WS; Cai MY; Zhou JW; Guo YJ; Zhu KS
World J Gastroenterol; 2018 Jan; 24(4):484-493. PubMed ID: 29398869
[TBL] [Abstract][Full Text] [Related]
54. BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A.
Jung YK; Jung CH; Seo YS; Kim JH; Kim TH; Yoo YJ; Kang SH; Yim SY; Suh SJ; An H; Yim HJ; Yeon JE; Byun KS; Um SH
J Gastroenterol Hepatol; 2016 Feb; 31(2):467-74. PubMed ID: 26332049
[TBL] [Abstract][Full Text] [Related]
55. Subclassification of Barcelona Clinic Liver Cancer B and C hepatocellular carcinoma: A cohort study of the multicenter registry database.
Lee S; Kim BK; Song K; Park JY; Ahn SH; Kim SU; Han KH; Kim DY;
J Gastroenterol Hepatol; 2016 Apr; 31(4):842-7. PubMed ID: 26513311
[TBL] [Abstract][Full Text] [Related]
56. Cancer of the Liver Italian Program score helps identify potential candidates for transarterial chemoembolization in patients with Barcelona Clinic Liver Cancer stage C.
Li L; Gou CY; Li JY; Achakzai R; Li XH
Hepatobiliary Pancreat Dis Int; 2016 Apr; 15(2):152-7. PubMed ID: 27020631
[TBL] [Abstract][Full Text] [Related]
57. Enhanced therapeutic efficacy of combined use of sorafenib and transcatheter arterial chemoembolization for treatment of advanced hepatocellular carcinoma.
Zhou L; Li J; Ai DL; Fu JL; Peng XM; Zhang LZ; Wang JY; Zhao Y; Yang B; Yu Q; Liu CZ; Wang HM
Jpn J Clin Oncol; 2014 Aug; 44(8):711-7. PubMed ID: 24855686
[TBL] [Abstract][Full Text] [Related]
58. Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma.
Liu PH; Hsia CY; Lee YH; Hsu CY; Huang YH; Su CW; Lee RC; Lin HC; Huo TI
J Surg Oncol; 2015 Mar; 111(4):404-9. PubMed ID: 25643842
[TBL] [Abstract][Full Text] [Related]
59. Impact of Tumor Factors on Survival in Patients with Hepatocellular Carcinoma Classified Based on Kinki Criteria Stage B2.
Arizumi T; Minami T; Chishina H; Kono M; Takita M; Yada N; Hagiwara S; Minami Y; Ida H; Ueshima K; Kamata K; Minaga K; Komeda Y; Takenaka M; Sakurai T; Watanabe T; Nishida N; Kudo M
Dig Dis; 2017; 35(6):583-588. PubMed ID: 29040991
[TBL] [Abstract][Full Text] [Related]
60. Surgical resection improves the survival of selected hepatocellular carcinoma patients in Barcelona clinic liver cancer stage C.
Wang JH; Kuo YH; Wang CC; Chen CL; Cheng YF; Hsu HC; Lu SN
Dig Liver Dis; 2013 Jun; 45(6):510-5. PubMed ID: 23218990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
